Pfizer (United States)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2021

  1. Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression

    ACS Central Science, Vol. 7, Núm. 5, pp. 868-881